This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Dr. Mizue Hisano, PhD
Scientific Business Consultant, Genedata Biologics at Genedata
Speaker

Profile

In addition to receiving a Ph.D. in Pharmaceutical Science, Mizue Hisano has studied genetics, epigenetics, developmental biology, and cancer research in both the U.S. and Switzerland. As an Intellectual Property Law-trained expert, Dr. Hisano brings a unique blend of legal acumen and scientific insight to her current role as a Scientific Business Consultant at Genedata AG. Collaborating with Japanese biopharma companies, she focuses on cutting-edge data management platforms and digital solutions. She has an unwavering commitment to improve health by accelerating the delivery of life-saving medicines to people worldwide.

Agenda Sessions

  • Scientific Briefing: Faster Time to Market through Digital Innovation in Biologics Research and Development

    08:05